Zobrazeno 1 - 10
of 127
pro vyhledávání: '"Martha P Mims"'
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77409 (2013)
The incidence of Hodgkin lymphoma (HL) has increased since introduction of combined antiretroviral therapy (cART). While HIV-related HL is highly associated with EBV, the causes underlying the rising incidence remain unclear. The aim of this study wa
Externí odkaz:
https://doaj.org/article/a5183a7800f443b3a8d8fdafa09f6766
Autor:
Quillan Huang, Irene Mitsiades, Heidi Dowst, Neda Zarrin-Khameh, Attiya Batool Noor, Patricia Castro, Michael E. Scheurer, Guilherme Godoy, Martha P. Mims, Nicholas Mitsiades
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-8 (2023)
Abstract The rising utilization of circulating tumor DNA (ctDNA) assays in Precision Oncology may incidentally detect genetic material from secondary sources. It is important that such findings are recognized and properly leveraged for both diagnosis
Externí odkaz:
https://doaj.org/article/57fe4a7b16dc4018918af7f112ec4905
Autor:
Dov Kadmon, Michael M. Ittmann, Ming-Jer Tsai, J. Wade Harper, Thomas M. Wheeler, Brian J. Miles, Anna Frolov, R. Garret Lynch, Vivian MacDonnell, Teresa G. Hayes, Martha P. Mims, Timothy C. Thompson, Yi Ding, Rile Li, Jun Yan, Gustavo Ayala
Purpose: To assess the safety of administering bortezomib to patients undergoing a radical prostatectomy, to assess pathologic changes induced by bortezomib in prostate cancer specimen, and to verify alterations by the drug in proteasome protein targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05441741c21215efc574ce5cc8976394
https://doi.org/10.1158/1078-0432.c.6516892.v1
https://doi.org/10.1158/1078-0432.c.6516892.v1
Autor:
Dov Kadmon, Michael M. Ittmann, Ming-Jer Tsai, J. Wade Harper, Thomas M. Wheeler, Brian J. Miles, Anna Frolov, R. Garret Lynch, Vivian MacDonnell, Teresa G. Hayes, Martha P. Mims, Timothy C. Thompson, Yi Ding, Rile Li, Jun Yan, Gustavo Ayala
Supplementary Data from Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated Akt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ad9d2c5940a34b1368d67042051c00
https://doi.org/10.1158/1078-0432.22439422.v1
https://doi.org/10.1158/1078-0432.22439422.v1
Autor:
Courtney Nicole Miller-Chism, Harinder S. Juneja, Curtis Lachowiez, Hilary Y. Ma, Martha P. Mims, Wei Qiao, Onyebuchi Ononogbu, Mark M. Udden, Effrosyni Apostolidou
Publikováno v:
Clin Lymphoma Myeloma Leuk
Despite therapeutic advances and improvement in outcomes of patients with acute lymphoblastic leukemia, as reported by specialized centers, healthcare disparities exist. This is a retrospective cohort analysis of the clinical outcomes of 146 patients
Autor:
Nikhil Patel, Gustavo Rivero, Martha P. Mims, Purnima Sravanti Teegavarapu, Gianfranco Bittar, Diana De Oliviera
Publikováno v:
Blood. 140:6112-6113
Autor:
Kevin Tang, Heidi M Krause, Nikhil Patel, Grace Hwang, Jason Lu, Martha P. Mims, Mark M. Udden, Courtney Nicole Miller-Chism, Gustavo Rivero, Purnima Sravanti Teegavarapu
Publikováno v:
Blood. 140:8101-8102
Publikováno v:
Blood. 140:8934-8935
Publikováno v:
Cancer Research. 80:P2-10
BACKGROUND African Americans comprise 12% of the total United States population. Lifetime probability of developing cancer in African Americans is 37.55%. Lifetime probability of developing breast cancer in African Americans is 11.1%. African America